Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
- Resource Type
- Article
- Authors
- Moore, Kathleen N; Secord, Angeles Alvarez; Geller, Melissa A; Miller, David Scott; Cloven, Noelle; Fleming, Gini F; Wahner Hendrickson, Andrea E; Azodi, Masoud; DiSilvestro, Paul; Oza, Amit M; Cristea, Mihaela; Berek, Jonathan S; Chan, John K; Rimel, Bobbie J; Matei, Daniela E; Li, Yong; Sun, Kaiming; Luptakova, Katarina; Matulonis, Ursula A; Monk, Bradley J
- Source
- In The Lancet Oncology May 2019 20(5):636-648
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045